From our point of view, Bioxtran is a highly undervalued asset with exceptionally strong clinical trial data that warrants further development. We are very happy to provide the capital needed to ...
A team of Harvard scientists has, for the first time, successfully trapped molecules to execute quantum operations. This breakthrough was achieved using ultra-cold polar molecules as qubits—the basic ...